Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer; no changes to core study content such as title, conditions, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section updated with new site entries across multiple countries (California, Connecticut, Illinois, Ohio, Oregon, Pennsylvania, Italy, New Zealand, Eastern Cape, Turkey). Revision tag updated to v3.3.3.SummaryDifference1.0%

- Check48 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1, which is a cosmetic metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1, with no changes to study details, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAn administrative banner regarding government funding and NIH operating status, previously shown on the study page, has been removed.SummaryDifference0.3%

- Check76 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the page text and structure appear unchanged.SummaryDifference0.4%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.